Anticoagulation response to warfarin is unpredictable because of the wide interindividual variability in dose requirement and the drug's narrow therapeutic index. The aim of my PhD project was to ftirther investigate and identify factors that contribute to the variability in warfarin dose requirements. Identification of the factors contributing to the variability could help toward improving the safety of warfarin through personalized therapy.